The Biomarker Science team at IXICO specializes in the identification and validation of biomarkers for neurological and psychiatric disorders such as Alzheimer's, Huntington's, and Parkinson's diseases. This team employs advanced medical imaging and analytical techniques to support drug development and enhance clinical trial outcomes, thereby contributing to the company's mission of improving brain health.